Abstract
Introduction
Patients with type 2 diabetes are known to have a higher risk of developing micro- and macrovascular complications which enhance the risk of morbidity and mortality. Increased platelet activity is postulated to be a vital mechanism in the development of vascular complications. Platelet volume indices (PVI), including mean platelet volume (MPV), platelet distribution width (PDW), and plateletcrit (PCT) are indicators of enhanced platelet activity and these may be useful markers of complications.
Materials and methods
We conducted a case-control study across 130 T2DM patients that were matched for age and gender with 130 people who did not have T2DM. Detailed demographic profile and clinical history including duration of diabetes along with complete physical examination was conducted. Fundus examination was conducted for direct ophthalmoscopy for retinopathy and Neuropathy Disability Score (NDS) was calculated to assess the severity of neuropathy. The biochemical investigations included were the platelet indices, fasting blood glucose (FPG), postprandial blood glucose, HbA1c, serum creatinine, and urine albumin.
Results
We observed that platelet indices, such as MPV, PDW, and PCT were significantly higher in diabetic individuals than in matched controls. Higher MPV, PDW, and PCT were observed in diabetic patients with microvascular complications compared with those without microvascular complications. We observed that patients with neuropathy with NDS > 6 had higher value of MPV, PDW, and PCT than compared with those with NDS < 6. There was significant difference for MPV between diabetics with and without complications and non-diabetics (p < 0.05). PDW and MPV were positively correlated with duration of diabetes.
Conclusions
The association between MPV, PDW, and PCT and diabetic retinopathy revealed that platelet indices were significantly higher than control group in both NPDR and PDR. However, we did not observe any difference in platelet indices in NPDR and patients without diabetic retinopathy. MPV, PDW, and PCT were higher in individuals with higher HbA1clevel and the correlation was found to be statistically significant.
Similar content being viewed by others
References
Adeghate E, Schattner P, Dunn E. An update on the etiology and epidemiology of diabetes mellitus. Ann N Y Acad Sci. 2006;1084:1–29.
Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–81.
Powers AC. Diabetes mellitus. In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Loscalzo J, Jameson JL, editors. Harrison’s principles of internal medicine. 20th ed. New York: McGraw-Hill; 2018. p. 2968–3002.
Marshall SM, Barth JH. Standardization of HbA1c measurements--a consensus statement. Diabet Med. 2000;17(1):5–6.
Ferroni P, Basili S, Falco A, Davì G. Platelet activation in type 2 diabetes mellitus. J Thromb Haemost. 2004;2(8):1282–91.
Coughlin SR. Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost. 2005;3(8):1800–14.
Buch A, Kaur S, Nair R, Jain A. Platelet volume indices as predictive biomarkers for diabetic complications in type 2 diabetic patients. J Lab Physicians. 2017;9(2):84–8.
Miettinen H, Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. Stroke. 1996;27(11):2033–9.
Walinjkar RS, Khadse S, Kumar S, Bawankule S, Acharya S. Platelet indices as a predictor of microvascular complications in type 2 diabetes. Indian J Endocrinol Metab. 2019;23(2):206–10.
Dindar S, Cinemre H, Sengul E, Annakkaya AN. Mean platelet volume is associated with glycaemic control and retinopathy in patients with type 2 diabetes mellitus. West Indian Med J. 2013;62(6):519–23.
Kodiatte TA, Manikyam UK, Rao SB, Jagadish TM, Reddy M, Lingaiah HK, et al. Mean platelet volume in type 2 diabetes mellitus. J Lab Physicians. 2012;4(1):5–9.
Pujani M, Gahlawat H, Agarwal C, Chauhan V, Singh K, Lukhmana S. Platelet parameters: can they serve as biomarkers of glycemic control or development of complications in evaluation of type 2 diabetes mellitus? Iraqi J Hematol. 2018;7:72–8.
Kshirsagar RM, Deoke S, Akhtar S. Panacea J Med Sci. 2019;9(1):23–8 10.18231.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Chawla, R., Sahu, J., Punyani, H. et al. Evaluation of platelet volume indices as predictive biomarkers of microvascular complications in patients with type 2 diabetes. Int J Diabetes Dev Ctries 41, 89–93 (2021). https://doi.org/10.1007/s13410-020-00852-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13410-020-00852-1